Section Arrow
PGEN.NASDAQ
- Precigen
Quotes are at least 15-min delayed:2024/10/31 18:37 EDT
Last
 0.79
-0.0336 (-4.08%)
Day High 
0.8379 
Prev. Close
0.8236 
1-M High
0.98 
Volume 
864.74K 
Bid
0.7811
Ask
0.8244
Day Low
0.7882 
Open
0.8379 
1-M Low
0.8233 
Market Cap 
241.02M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.89 
20-SMA 0.89 
50-SMA 0.97 
52-W High 1.93 
52-W Low 0.8233 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.54/-0.20
Enterprise Value
246.91M
Balance Sheet
Book Value Per Share
0.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.23M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improvedproducts and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.